Focal necrotizing myopathy with ‘dropped-head syndrome’ induced by cobimetinib in metastatic melanoma-Reference-Cited by-同舟云学术

Focal necrotizing myopathy with ‘dropped-head syndrome’ induced by cobimetinib in metastatic melanoma

Published:2017-10 Issue:5 Volume:27 Page:511-515
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Gauci Marie-Léa,Laly Pauline,Leonard-Louis Sarah,Behin Anthony,Gottlieb Jérémy,Madelaine-Chambrin Isabelle,Baroudjian Barouyr,Da-Meda Laetitia,Mourah Samia,Battistella Maxime,Basset-Seguin Nicole,Bagot Martine,Pages Cécile,Vercellino Laetitia,Maisonobe Thierry,Lebbé Céleste

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference17 articles.

1. Combined vemurafenib and cobimetinib in BRAF -mutated melanoma;Larkin;N Engl J Med,2014

2. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N Engl J Med,2012

3. MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy;Tran;Drug Des Devel Ther,2016

4. A method for estimating the probability of adverse drug reactions;Naranjo;Clin Pharmacol Ther,1981

5. Mechanism and treatment of dropped head syndrome associated with parkinsonism;Oyama;Parkinsonism Relat Disord,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?;Cancers;2024-08-28

2. Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells;ACS Medicinal Chemistry Letters;2022-12-08

3. Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma;Journal of Immunotherapy and Precision Oncology;2022-02-01

4. Research progress of MEK1/2 inhibitors and degraders in the treatment of cancer;European Journal of Medicinal Chemistry;2021-06

5. Dropped Head Syndrome;JBJS Reviews;2020-01